OAKTREE CAPITAL MANAGEMENT LP - PDL BIOPHARMA INC ownership

Quarter-by-quarter ownership
OAKTREE CAPITAL MANAGEMENT LP ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q4 2017$7,296,000
+47.7%
7,287,000
+47.5%
0.11%
+54.1%
Q3 2017$4,940,000
-1.0%
4,940,000
-1.2%
0.07%
-9.8%
Q2 2017$4,989,000
-45.5%
5,000,000
-45.7%
0.08%
-38.3%
Q1 2017$9,157,000
+43.8%
9,200,000
+41.5%
0.13%
+41.5%
Q4 2016$6,369,000
-41.3%
6,500,000
-41.4%
0.09%
-33.3%
Q3 2016$10,842,000
-10.8%
11,091,000
-13.3%
0.14%
-35.6%
Q2 2016$12,160,000
+20.3%
12,791,000
+15.0%
0.22%
+20.3%
Q1 2016$10,106,000
+53.2%
11,121,000
+34.1%
0.18%
+109.2%
Q4 2015$6,595,000
-47.0%
8,296,000
-41.3%
0.09%
-46.6%
Q3 2015$12,446,000
-7.4%
14,138,0000.0%0.16%
+4.5%
Q2 2015$13,444,000
+38.4%
14,138,000
+39.5%
0.16%
+52.9%
Q1 2015$9,715,00010,138,0000.10%
Other shareholders

There were no reported owners of PDL BIOPHARMA INC in Q3 2023.

NameSharesValueWeighting ↓
View complete list of PDL BIOPHARMA INC shareholders